This page covers both, with the oral route first
A comparison with antidepressants
Beyond angiogenesis, BPC-157 also modulates the nitric oxide system (which plays a role in tissue protection), increases FAK-paxillin expression (involved in cell adhesion and growth), and has been shown in animal studies to reduce inflammatory cytokines
Interventions included oral GABA (1 gram/M2/day up to a maximum of 1.5 gram/day or approximately 30 mg/kg/day, see Figure 2 ) divided into two daily doses with or without two GAD-alum injections (20 mcg/dose)-one at baseline and the other at one month
This mechanism alone accounts for significant weight loss, as demonstrated by single-agonist medications achieving 15-17% weight reduction
There was a survodutide dose-dependent decrease in bodyweight up to 8.7% with the high-dose survodutide producing greater bodyweight reduction compared to semaglutide [48]